Public Employees Ask PEIA Not To Raise Rates

State employees had the opportunity Monday evening to make their voices heard about proposed rate increases to their health insurance.

State employees had the opportunity Monday evening to make their voices heard about proposed rate increases to their health insurance.

About 160 people attended a virtual public hearing held by the West Virginia Public Employees Insurance Agency (PEIA), to hear proposed changes to their health insurance for Plan Year 2026, beginning July 1, 2025.

On Oct. 24, PEIA and the Retiree Health Benefit Trust (RHBT) Finance Board met to discuss proposed changes to rates.

Brian Cunningham, the director of PEIA, presented the Finance Board’s proposed rate increases, then took questions and comments from the audience.

The board’s proposal includes a projected five-year plan to raise member payments and restore PEIA reserves. Those proposals include more than doubling some copays along with premium increases through 2029.

Cunningham said the rate increases can be attributed to the passage of Senate Bill 268.

The 2023 bill mandated a spousal surcharge and formalized the 80/20 rule, which requires insurance companies to spend at least 80 percent of the money they take in from premiums on health care costs and quality improvement activities.

“As it relates to spousal surcharge, the board is proposing a $350 spousal surcharge,” Cunningham said. “Currently, that spousal surcharge is $147.”

The bill also required PEIA to increase reimbursement to healthcare providers.

“The other things that are driving cost increases, (you) may have heard of Senate Bill 268, which resulted in increased reimbursement to healthcare providers,” Cunningham said. “In plan year 2024 PEIA paid out more than $70 million more in healthcare providers and reimbursement to healthcare providers, particularly inpatient hospitals.”

Finally, Cunningham said, rising prescription drug costs are spurring rate increases for employees.

“A significant driver of the cost of prescription drugs are what are known as GLP-1’s,” Cunningham said. “GLP-1’s are prescription drugs like Ozempic and Mounjaro. GLP-1’s were responsible for almost $53 million in cost in plan year 2024 which is approximately 20 percent of the overall net cost, or the overall net drug spend at PEIA.”

In March, PEIA canceled a 1,000-person pilot program that covered weight-loss drugs due in part to the program’s cost to the state. However, advocates of the program say the state will end up paying more for the health complications that will be caused by obesity.

West Virginia state employees from all walks of life voiced their concerns about increasing healthcare costs.

Retirees on the call say they worked their lives for their retirement, and these rate increases will not be feasible on a fixed income.

Teachers on the call say their salaries do not cover their expenses, but they have continued to work their state jobs for the benefits because it outweighed the cost and they care about their work.

Jamie Tallman was one of 165 West Virginians on the virtual call who spoke during Monday’s hearing. He has been teaching in Grant County for almost 40 years.

He says he and his wife will have to consider selling their home and downsizing if the rate increases are implemented. That echoes sentiments from his fellow state educators that affordable health benefits were leveling out the low salaries provided by the state.

“This would be the most severe pay cut, basically, that I would receive as an educator in all my career. And I know somebody said last night, it is a perk,” Tallman said. “The insurance has kind of been a perk, you know.  We work right up there, 49th, 50th, you know, in teacher salary.”

Most speakers said if the rates are raised they will have to consider leaving the state entirely or stopping work for the state.

Cunningham encouraged PEIA members to reach out to their lawmakers to let them know their concerns.

PEIA is continuing to hold public hearings throughout the week.

PEIA Director: Agency Making Strides In Controlling Prescription Costs, Advancing Wellness 

Brian Cunningham said whenever he’s out in public, he’s bombarded with questions on when PEIA will cover the new anti-obesity drugs, including Wegovy.

West Virginia’s Public Employees Insurance Agency (PEIA) Director Brian Cunningham said he’s working on several fronts to reduce the latest round of premium increases that were approved last week. 

Speaking to the interim Joint Standing Committee on Insurance and PEIA on Monday, Cunningham said the agency is seeking some initial prescription cost reducing opportunities around diabetes, weight management and migraine medications. 

“We’re taking an incremental approach to comparative effectiveness to minimize provider and member disruption,” Cunningham said.

Cunningham told lawmakers PEIA is leveraging the 340B Drug Pricing Program. He explained it allows Federally Qualified Health Centers (FQHC) to buy medications at a savings. 

“(Getting entities such as) disproportionate share hospitals, critical access hospitals, community behavioral health centers, and other covered entities to buy at a very low cost,” Cunningham said. “For example, an AWP (Average Wholesale Price) at minus 50, 60, and even 70 percent in some cases, 

Cunningham said the agency is also consolidating a number of wellness programs under a cost saving single management structure with one vendor. 

“We’re targeting diabetes, weight management and behavioral health,” Cunningham said. “All problems that we face here in the state of West Virginia.”

Cunningham said a number of expanding PEIA online wellness programs also target weight loss and controlling diabetes.

“That is a bit of a shared savings model,” Cunningham said. “I believe one online program is called Cecelia, one is called DayTwo, both for weight loss. We’ve got a face to face diabetes program that is managed at local pharmacies. And then we have a host of other programs.” 

Cunningham answered a question about the PEIA CapitalRX vendor and their “diabetes guarantee,” intended to protect against the spiraling cost of diabetes drugs.

“Think of the Ozempics of the world,” he said. “Which is certainly a cost driver for PEIA right now. If the target cost of those drugs is exceeded, the guarantee kicks in and PEIA is paid back for some of the cost of those drugs.”

Cunningham said whenever he’s out in public, he’s bombarded with questions on when PEIA will cover the new anti-obesity drugs, including Wegovy.

“The reason we have such tight controls and a limited prescribing network for those weight loss drugs, is, in part, because of the cost to plan,” Cunningham said. “If we just opened up, Wegovy for example, and let anybody prescribe it, instead of a 10 and a half percent premium increase, I’d be standing before you here saying it’s a 15 percent premium increase or more.” 

Cunningham said later those numbers were an estimate. He told lawmakers he understands that people who have been on Ozempic, for example, may benefit from continuing to remain on Ozempic. He said those are things that PEIA is “looking at and studying right now internally.”

Exit mobile version